RO:SWX
Roche Holding AG
CHFÂ 362.80
0.00%
(0.00) 1D
Sep 30, 2:01:40 PM GMT+2 · CHF
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RO...
Open
CHFÂ 364.00
High
CHFÂ 366.20
Low
CHFÂ 361.80
Mkt. cap
285.23B
Avg. vol.
31.62K
Volume
2.85K
Dividend
2.70%
Quarterly dividend
CHFÂ 2.45
Ex-dividend date
Mar 27, 2025
P/E ratio
23.67
52-wk high
CHFÂ 383.00
52-wk low
CHFÂ 264.60
EPS
CHFÂ 15.33
Shares outstanding
106.69M
No. of employees
113K
Open
CHFÂ 364.00
High
CHFÂ 366.20
Low
CHFÂ 361.80
Mkt. cap
285.23B
Avg. vol.
31.62K
Volume
2.85K
Dividend
2.70%
Quarterly dividend
CHFÂ 2.45
Ex-dividend date
Mar 27, 2025
P/E ratio
23.67
52-wk high
CHFÂ 383.00
52-wk low
CHFÂ 264.60
EPS
CHFÂ 15.33
Shares outstanding
106.69M
No. of employees
113K
News stories
From web sources and news partners
Stock Titan
·
7 hours ago
One trial found Roche's experimental MS treatment cut relapse rates by 58.5% versus standard care.
AD HOC NEWS
·
17 hours ago
Roche Holding stock after-hours: Pharma Day highlights AI-driven R&D plans
Reuters
·
1 day ago
Roche outlines plans to move towards autonomous AI labs
WSJ
·
1 day ago
Roche Halts Development of Obesity Drug Candidate
Profile
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76.
The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021.
F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
About Roche Holding AG
CEOThomas Schinecker
Employees113K
FoundedOct 1, 1896
HeadquartersBasel, Basel City, Switzerland
SectorPharmaceutical industry
Websiteroche.com